Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis
Introduction Evidence suggests a potentially causal role of interleukin 6 (IL-6), a pleiotropic cytokine that generally promotes inflammation, in the pathogenesis of psychosis. However, no interventional studies in patients with psychosis, stratified using inflammatory markers, have been conducted t...
Main Authors: | Stephen Burgess, Peter Jones, Rachel Upthegrove, Carmine Pariante, Graham K Murray, Anthony David, Martin Wilson, Nicholas Barnes, Paola Dazzan, John Suckling, Valeria Mondelli, Muzaffer Kaser, Neil Harrison, Georgios Gkoutos, Golam M Khandaker, Deepak Jadon, James MacCabe, Gary Donohoe, Alice Egerton, Bill Deakin, Jack Rogers, Éimear M Foley, Sian Lowri Griffiths, Alexander Murray, Fabiana Corsi-Zuelli, Hannah Hickinbotham, Ella Warwick, Nicholas M Barnes, Golam Khandaker, David Cotter, Ed Bullmore, Eva Meisenzahl, Joanna Neill, Nikos Koutsouleris, Stephen Wood |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-03-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/13/3/e067944.full |
Similar Items
-
A systematic review of cognitive function in first-episode psychosis, including a discussion on childhood trauma, stress and inflammation
by: Monica eAas, et al.
Published: (2014-01-01) -
Heterogeneity in treatment outcomes and incomplete recovery in first episode psychosis: does one size fit all?
by: Siân Lowri Griffiths, et al.
Published: (2022-11-01) -
What causes the onset of psychosis?
by: Broome, MR, et al.
Published: (2005) -
Predicting treatment resistance in people with a first-episode of psychosis using commonly recorded clinical information
by: E.F. Osimo, et al.
Published: (2022-06-01) -
Social Disadvantage: Cause or Consequence of Impending Psychosis?
by: Stilo, SA, et al.
Published: (2013)